Regarding main clinical outcome , analysis of variance ( ANOVA ) was performed to evaluate mean change scores in depressive symptoms as assessed by the HDRS-17 between baseline ( t1 ) , after intervention protocol ( t2 ) , and during one-month follow-up ( t3 ) .